亞太衞星(01045.HK)委任汪鴻濱及閆釗為執行董事
格隆匯3月30日丨亞太衞星(01045.HK)公佈,程廣仁因另有工作安排辭任公司執行董事、總裁及公司根據《證券上市規則》及《公司條例》第16部之授權代表職務。齊良因退休辭任公司執行董事、副總裁、提名委員會及薪酬委員會成員。
同日宣佈,於2022年3月30日起,委任汪鴻濱為公司執行董事兼總裁及公司根據《證券上市規則》及《公司條例》第16部之授權代表;委任閆釗為公司執行董事兼副總裁。汪鴻濱負責公司全面管理工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.